Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.
Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- ChecktodayChange DetectedThe additions and deletions appear to be timestamp updates for the page rather than changes to core study content (e.g., eligibility, arms, outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check8 days agoChange DetectedAdded a dedicated Locations section with Florida as a study site, replacing the previous Florida Locations label; the page revision is shown as v3.3.3.SummaryDifference0.2%
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows a minor revision update from v3.3.1 to v3.3.2, with no changes to study data, eligibility, contacts, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check36 days agoChange DetectedThe revision label updated from v3.2.0 to v3.3.1 with no substantive changes to the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check43 days agoChange DetectedAdded branding references for H. Lee Moffitt Cancer Center and a 'Helpful Links Provided by' section. Removed the NIH operating-status notice from the page.SummaryDifference0.5%
- Check58 days agoChange DetectedNo significant changes were detected on the Study Details page for NCT02638090. The content appears unchanged.SummaryDifference0.4%
Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.